Treatment of Thyroid Storm with Diarrhea, Nausea, Vomiting, Jaundice, or Elevated Bilirubin (≥ 3.0 mg/dL)
Thyroid storm can involve significant gastrointestinal and hepatic compromise. When these manifestations are present, the treatment plan requires additional, targeted steps specific to this sub-population.
Clinical Scenario
This protocol addresses thyroid storm patients presenting with gastrointestinal (GI) or hepatic manifestations — specifically nausea, vomiting, diarrhea, jaundice, or a total bilirubin level ≥ 3.0 mg/dL.
Treatment Approach (Partial)
Acid-suppressive therapy is part of the approach for patients at risk of gastrointestinal hemorrhage, and additional agents targeting hepatic damage may also be considered — the full selection, sequencing, and patient-specific criteria are in the complete protocol.
Treatment Goals
- Resolution of gastrointestinal symptoms
- Reduction in total bilirubin level
References
- Gastrointestinal (GI)/hepatic manifestations : nausea , vomiting, diarrhea, or a total bilirubin level ≥ 3.0 mg/dL
- Acid-suppressive drugs such as proton pump inhibitors (PPIs) or histamine-2 receptor antagonists (H2As) are recommended for patients in these instances.
- Ursodeoxycholic acid, which relieves liver dysfunction, and Stronger Neo-Minophagen C, a glycyrrhizin-containing liver protector, can also be used; however, these drugs may induce further liver damage.
View source ↗